229 related articles for article (PubMed ID: 33014148)
1. The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis.
Li WP; Gao HF; Ji F; Zhu T; Cheng MY; Yang M; Yang CQ; Zhang LL; Li JQ; Zhang JS; Wang K
Ther Adv Med Oncol; 2020; 12():1758835920958358. PubMed ID: 33014148
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
[TBL] [Abstract][Full Text] [Related]
3. Effect of adjuvant radiotherapy after breast-conserving surgery in elder women with early-stage breast cancer: a propensity-score matching analysis.
Han T; Shi M; Chen Q; Chen D; Hao J
Front Oncol; 2023; 13():1012139. PubMed ID: 37901322
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER.
Yang P; Zhang G; Zhang Y; Zhao W; Tang J; Zeng S; Lv X; Lv L
Radiat Oncol; 2024 May; 19(1):59. PubMed ID: 38773616
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of post-mastectomy adjuvant chemotherapy for the treatment of patients with prognostic stage IB breast cancer: A SEER-based study.
Wang H; Peng Y; Wu J; Chen Z; Zhang H
Asian J Surg; 2023 Sep; 46(9):3634-3641. PubMed ID: 37210259
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
[TBL] [Abstract][Full Text] [Related]
7. Prognosis comparison between intraoperative radiotherapy and whole-breast external beam radiotherapy for T1-2 stage breast cancer without lymph node metastasis treated with breast-conserving surgery: A case-control study after propensity score matching.
Chen Q; Qu L; He Y; Xu J; Deng Y; Zhou Q; Yi W
Front Med (Lausanne); 2022; 9():919406. PubMed ID: 35991652
[TBL] [Abstract][Full Text] [Related]
8. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
Shang Y; Wang X; Liu Y; Cheng W; Duan Y; Fang Z; Liu J; Kong F; Wang T; Yu T; Hu A; Zhang J; Zhang H; Li M; Rong Z; Li Y; Shakila SS; Li X; Feng J; Ma F; Guo B
Breast Cancer; 2024 Apr; ():. PubMed ID: 38643430
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Adjuvant Treatments for Adenoid Cystic Carcinoma of the Breast: A Population-Based, Propensity Score Matched Cohort Study from the SEER Database.
Yang L; Wang C; Liu M; Wang S
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885663
[TBL] [Abstract][Full Text] [Related]
10. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
Lin Y; Huang K; Zeng Q; Zhang J; Song C
PeerJ; 2020; 8():e8694. PubMed ID: 32219021
[TBL] [Abstract][Full Text] [Related]
11. Survival outcome of adjuvant chemotherapy and high 21-gene recurrence score in early-stage breast cancer.
Ma SJ; Oladeru OT; Farrugia M; Mikucki M; Iovoli A; Shekher R; Sood A; Singh AK
Breast J; 2021 Jan; 27(1):27-34. PubMed ID: 33274486
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of adjuvant chemotherapy in elderly patients with stage I triple-negative breast cancer: a cohort study based on the SEER database.
Zhang Y; Liu X; Ma M; Chen C; Wang X
Transl Cancer Res; 2023 Jul; 12(7):1741-1752. PubMed ID: 37588733
[TBL] [Abstract][Full Text] [Related]
13. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
[TBL] [Abstract][Full Text] [Related]
14. The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy.
Fu WF; Chen QX; Wang XX; Zhang J; Song CG
Front Oncol; 2020; 10():1753. PubMed ID: 33102205
[No Abstract] [Full Text] [Related]
15. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
16. Effect of radiation therapy on patients with stage T3 or T4 malignant phyllodes tumors: a retrospective observational study based on SEER.
Zhang G; Yang P; Zeng J; Wei C
J Cancer Res Clin Oncol; 2023 Dec; 150(1):2. PubMed ID: 38153521
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer.
Bravo-Solarte DC; Zhang F; Anampa JD
Clin Breast Cancer; 2023 Oct; 23(7):763-773.e6. PubMed ID: 37648557
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a prognostic nomogram for early HER2-positive and lymph node-negative breast cancer.
Shi Q; Wang J; Ai X; Xuhong J; Ma D; Zhang Y; Qi X; Jiang J
Gland Surg; 2021 Jul; 10(7):2255-2265. PubMed ID: 34422596
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
Yao Y; Chu Y; Xu B; Hu Q; Song Q
Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
